Bill

Bill > H0697


FL H0697

FL H0697
Drug Prices and Coverage


summary

Introduced
12/09/2025
In Committee
03/05/2026
Crossed Over
03/10/2026
Passed
03/24/2026
Dead
Signed/Enacted/Adopted
03/25/2026

Introduced Session

2026 Regular Session

Bill Summary

An act relating to drug prices and coverage; amending s. 626.8825, F.S.; revising the definition of the term "pharmacy benefits plan or program" to exclude a plan or program that exclusively serves a PACE organization; requiring contracts between pharmacy benefit managers and participating pharmacies to allow a specified option in the administrative appeal procedure; amending s. 626.8827, F.S.; providing pharmacy benefit manager prohibited practices relating to pharmacies and pharmacists; providing an appropriation for implementation of the Ryan White Part B AIDS Drug Assistance Program (ADAP) through a specified date; defining the term "low income" for purposes of ADAP eligibility through a specified date; providing requirements for the implementation of ADAP through a specified date; requiring the Department of Health to submit monthly reports providing a detailed accounting of ADAP to the Governor's Office of Policy and Budget and the chairs of the legislative appropriations committees; specifying requirements for the reports; requiring the department to adopt emergency rules to implement ADAP; providing that such emergency rules are exempt from specified rulemaking requirements and remain in effect through a specified hb697 -02-er2026 Legislature date; providing effective dates.

AI Summary

This bill modifies existing Florida law concerning pharmacy benefits plans and programs, pharmacy benefit managers (PBMs), and the Ryan White Part B AIDS Drug Assistance Program (ADAP). It clarifies that a "pharmacy benefits plan or program" does not include plans exclusively serving a PACE (Program of All-Inclusive Care for the Elderly) organization. Contracts between PBMs and pharmacies will now require an option for pharmacies to submit consolidated administrative appeals for multiple adjudicated claims that share the same drug and supply details within the same calendar month, aiming to streamline the process of challenging reimbursement rates. The bill also introduces new prohibited practices for PBMs, preventing them from restricting pharmacies from refusing to dispense drugs if the reimbursement rate is below their actual acquisition cost, and prohibiting PBMs from reimbursing affiliated pharmacies at a higher rate than non-affiliated ones. Furthermore, it appropriates over $30 million for the implementation of ADAP through June 30, 2026, defining "low income" for ADAP eligibility as an adjusted gross household income at or below 400% of the federal poverty level during this period. ADAP services will be provided through direct medication distribution, not health insurance, and must include all medications on the Florida ADAP Formulary as of March 1, 2026, with specific provisions for individuals with impaired kidney function. The Department of Health is mandated to submit monthly reports detailing ADAP's finances, participant data, and operational status to legislative and executive offices, and is authorized to adopt emergency rules to implement ADAP, which will remain in effect until June 30, 2026.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (10)

Other Sponsors (1)

Health & Human Services Committee (House)

Last Action

Chapter No. 2026-4 (on 03/25/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...